Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase
Related Experiment Video
Updated: Mar 8, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Ruchi Jain Dey1,2, Bappaditya Dey1,2, Yue Zheng3,4
1Center for Tuberculosis Research, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
Mycobacterium tuberculosis infection leads to cytosolic release of the bacterial cyclic dinucleotide (CDN) c-di-AMP and a host-generated CDN, cGAMP, both of which trigger type I interferon (IFN) expression in a STING-dependent manner. Here we report that M. tuberculosis has developed a mechanism to inhibit STING activation and the type I IFN response via the bacterial phosphodiesterase (PDE) CdnP, which mediates hydrolysis of both bacterial-derived c-di-AMP and host-derived cGAMP. Mutation of cdnP attenuates M. tuberculosis virulence, as does loss of a host CDN PDE known as ENPP1. CdnP is inhibited by both US Food and Drug Administration (FDA)-approved PDE inhibitors and nonhydrolyzable dinucleotide mimetics specifically designed to target the enzyme. These findings reveal a crucial role of CDN homeostasis in governing the outcome of M. tuberculosis infection as well as a unique mechanism of subversion of the host's cytosolic surveillance pathway (CSP) by a bacterial PDE that may serve as an attractive antimicrobial target.
Insights
Mycobacterium tuberculosis uses a bacterial enzyme, CdnP, to block the host immune response. Inhibiting this enzyme could be a new way to treat tuberculosis.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Mycobacterium tuberculosis infection triggers host cytosolic surveillance pathways (CSP) via cyclic dinucleotides (CDNs), leading to type I interferon (IFN) expression.
- This innate immune response is crucial for controlling bacterial infections but can be subverted by pathogens.
Purpose of the Study:
- To investigate the mechanism by which Mycobacterium tuberculosis evades the host's type I IFN response.
- To identify bacterial factors involved in subverting the cytosolic surveillance pathway (CSP).
Main Methods:
- Enzyme activity assays to measure hydrolysis of c-di-AMP and cGAMP by CdnP.
- Genetic manipulation of Mycobacterium tuberculosis (mutation of cdnP) to assess virulence.
- Testing the efficacy of FDA-approved phosphodiesterase (PDE) inhibitors and dinucleotide mimetics against CdnP.
Main Results:
- Mycobacterium tuberculosis possesses a phosphodiesterase (PDE) enzyme, CdnP, that degrades both bacterial c-di-AMP and host cGAMP.
- Loss of CdnP function or host ENPP1 attenuates bacterial virulence, indicating their importance in infection.
- CdnP is effectively inhibited by specific PDE inhibitors and dinucleotide mimetics.
Conclusions:
- Mycobacterium tuberculosis subverts host immunity by hydrolyzing key signaling molecules (CDNs) through its PDE, CdnP.
- CDN homeostasis is critical for controlling M. tuberculosis infection.
- Bacterial PDE CdnP represents a potential novel antimicrobial target for tuberculosis treatment.
More Related Videos
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing
Stringent Response in E. coli
The JAK-STAT Signaling Pathway
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...